Pharmacogenetic determinants of outcomes on triplet hepatic artery infusion and intravenous cetuximab for liver metastases from colorectal cancer (European trial OPTILIV, NCT00852228)

from Cancer via ola Kala on Inoreader http://ift.tt/2y7eqb8
via IFTTT